Cargando…
Inhibitory Effect of a Novel Antirheumatic Drug T-614 on the IL-6-Induced RANKL/OPG, IL-17, and MMP-3 Expression in Synovial Fibroblasts from Rheumatoid Arthritis Patients
T-614 (also named as iguratimod), a novel antirheumatic drug, could attenuate joint inflammation and articular damage in rheumatoid arthritis (RA) patients, providing a new therapy for RA. Here, we tested the role T-614 on the IL-6-induced receptor activator of nuclear factor κB ligand (RANKL)/osteo...
Autores principales: | Wei, Yu, Sun, Xiaoxun, Hua, Minhui, Tan, Wenfeng, Wang, Fang, Zhang, Miaojia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530218/ https://www.ncbi.nlm.nih.gov/pubmed/26273599 http://dx.doi.org/10.1155/2015/214683 |
Ejemplares similares
-
Modulatory Effect of 1,25-Dihydroxyvitamin D(3) on IL1β-Induced RANKL, OPG, TNFα, and IL-6 Expression in Human Rheumatoid Synoviocyte MH7A
por: Feng, Xiaoke, et al.
Publicado: (2013) -
IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients
por: Xu, Lingxiao, et al.
Publicado: (2013) -
Effects of IL-10 and glucose on expression of OPG and RANKL in human
periodontal ligament fibroblasts
por: Zhang, L., et al.
Publicado: (2016) -
OPG and RANKL in serum and synovial fluids of patients with rheumatoid arthritis, osteoarthritis and spondylarthropathy
por: Krystufkova, O, et al.
Publicado: (2003) -
TLR2 Elicits IL-17-Mediated RANKL Expression, IL-17, and OPG Production in Neutrophils from Arthritic Mice
por: Milanova, Viktoriya, et al.
Publicado: (2014)